SouthState’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
SouthState's VKTX Position: Q3 2026 in Review
SouthState held its Viking Therapeutics (VKTX) position steady in Q3 2026 at 10 shares worth $326. The position accounts for ﹤0.01% of the portfolio, ranked #1330.
SouthState first reported a position in VKTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.69K in Q1 2025. 322 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- SouthState held 10 shares of Viking Therapeutics worth $326 as of Q3 2026.
- SouthState left its Viking Therapeutics share count unchanged in Q3 2026.
- Viking Therapeutics made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1330 holding.
- SouthState first reported a position in Viking Therapeutics in Q1 2025 and has held it in 7 quarters since.
- SouthState's Viking Therapeutics position peaked at $1.69K in Q1 2025.
- 322 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.